A new class of drugs that fight migraines could cost as much as $10,000 a year, NBC News reports. » Read More
The death rate from drug overdoses more than doubled between 1999 and 2015, according to a report from the CDC. » Read More
By: Lauren Thomas
Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500. » Read More
By: Ali Vitali
Vice President Mike Pence issued a proclamation to the Conservative Political Action Conference Thursday: the "Obamacare nightmare is about to end." » Read More
Morgan Stanley's 2020 earnings-per-share estimate for Merck is $5.82 versus the Wall Street consensus of $4.97.
Trump's Obamacare remarks came at a news conference that was his first since being elected president of the United States.
The iShares Nasdaq Biotechnology ETF (IBB) briefly fell more than 2.5 percent, tracking for its first negative day of 2017.
More than $19 billion was given to 5.2 million people to reduce their insurance premiums in 2015.
Nygren, who manages $16 billion as part of the Oakmark Fund, reveals his favorite health-care stocks for 2017.
"I truly understand the outrage when you have no idea what something's going to cost," said Heather Bresch.
Crafting and passing a replacement plan for Obamacare is seen as very difficult, if not impossible, in the short term.
Scientists have repeatedly said there is no link between autism and vaccinations.
Valeant has recently been trying to sell off its noncore assets to reduce its acquired mass amounts of debt.
The Obama administration starkly warned Republicans against a "repeal-and-delay" strategy on Obamacare.
Illumina surged 16 percent on Tuesday, a day after the firm unveiled a new gene-sequencing product.
Repealing the Affordable Care Act might mean lost jobs, longer workdays and delayed retirement, NBC News reports.
Valeant Pharmaceuticals said that the sale's proceeds will be used to pay down debt.
Business is waking up to the importance of sleep.
Ariad Pharmaceuticals investors are having a good day.
UnitedHealth's Optum unit said it would buy Surgical Care Affiliates for about $2.3 billion.
Theranos has announced its latest round of job cuts, firing 155 employees to leave a "core team" of just 220.
President Barack Obama says Republicans must put forward a replacement to Obamacare before they repeal it.
Japan's Takeda Pharmaceutical said on Monday it would acquire cancer drugmaker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion.
That leaves 220 workers to focus on Theranos' business plans.
Get the best of CNBC in your inbox